Etiometry 2025 Highlights and Looking Ahead to 2026

Blog

  • Delivered major platform advancements and expanded hospital adoption, informing the care of more than 425,000 patients to date.
  • Secured our 10th FDA clearance, validating enhanced cybersecurity protections for hospitals and patients.
  • Advanced the platform with deeper incorporation of high-resolution waveform data, enabling richer physiological insights at the point of care.
  • Earned the 2025 Digital Health Hub Award – Best in Class: AI in Patient Care at the HLTH conference.
  • Published a record number of clinical studies with leading institutions, strengthening evidence across pediatric and adult critical care.
  • Continued focus on our Cardiac Critical Care Solution, supporting clinicians by organizing and displaying patient data to aid decision-making in intensive care settings.
  • Added the highest number of hospitals in company history, with notable growth among major health systems.
  • Expanded internationally, strengthening our presence in Europe and the Middle East through strategic partnerships.

As Shane Cooke, President and CEO of Etiometry, noted, the platform plays a proven role in improving care quality, reducing length of stay and ICU readmissions, lowering costs, easing care team burden, and improving documentation of complications.


We are building on this momentum with a clear focus on:

  • Expanding our presence in the adult cardiac market.
  • Accelerating international expansion in Europe and the Middle East.
  • Continuing to advance solutions to help identify and manage life-threatening conditions, including cardiogenic shock, respiratory failure, and sepsis/ARDS.


Related

First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams

Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]

The Business Case for Clinical Intelligence in the ICU. Is it a Worthwhile Investment?

Hospital operating margins remain thin and ICU cost is one of the largest line items in any high-acuity hospital. Clinical intelligence software, used as adjunctive support for clinician-directed care, has been associated with shorter ICU length of stay, fewer unplanned readmissions, and reduced ventilation time. Despite this, many senior hospital leaders are unsure of the […]

What is Clinical Intelligence Software and is it Ready for Clinical Reality?

ICU environments generate high volumes of physiologic data and alerts. “Alarm fatigue” is well documented in the literature, and it is linked to desensitisation, missed deterioration signals, and worse patient outcomes1. Clinical intelligence software can help here. It processes patient data continuously and highlights the risk signals that clinicians have defined as important, so teams […]